Results 221 to 230 of about 14,437,638 (295)

Moderate-Dose Local Radiotherapy in Symptomatic CD30-Positive, Anaplastic Lymphoma Kinase (ALK)-Negative Primary Cutaneous T-cell Lymphoma. [PDF]

Cureus
Varela A, Sepúlveda S, Evans NE, Araúz RE, Champsaur LM, D Orcy E, Samudio O.   +6 more
europepmc   +1 more source

Evidence on the Relationships Between Total Fat Intake and Health Outcomes Other Than Unhealthy Weight Gain in Adults and Children: A Scoping Review

Cochrane Evidence Synthesis and Methods, Volume 4, Issue 5, September 2026.
ABSTRACT Introduction Global guidance provides evidence‐informed recommendations on total fat intake to prevent unhealthy weight gain in adults and children, however, evidence regarding total fat intake and other health outcomes, particularly non‐communicable diseases (NCDs), also exists.
Marianne Visser, Sarah Gordon, Amanda Brand, Anel Schoonees, Celeste Naude   +4 more
wiley   +1 more source

Evaluating mogamulizumab in the treatment of primary cutaneous T-cell lymphoma. [PDF]

Immunotherapy
Oymanns M, Elsayad K, Wilms L, Dimmers F, Daum-Marzian M, Abu-Dawud R, Motiei M, Assaf C.   +7 more
europepmc   +1 more source

Immune Checkpoint Inhibitors in Relapsed/Refractory Anaplastic Large Cell Lymphoma (ALCL): A Case Report and Review of the Literature

Cancer Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background While immune checkpoint inhibitors (ICI) have transformed the landscape of clinical oncology, their application in rare malignancies such as anaplastic large cell lymphoma (ALCL) remains limited. Case We report a patient with relapsed/refractory (r/r) ALCL treated at the University Hospital Krems who achieved sustained complete ...
Constantin Klenner, Josef Singer
wiley   +1 more source

Intermediate-dose TBI/fludarabine conditioning for allogeneic hematopoietic cell transplantation in patients with cutaneous T-cell lymphoma. [PDF]

Bone Marrow Transplant
Krämer I, König L, Brecht A, Hassel JC, Luft T, Hegenbart U, Eichkorn T, Stadtherr P, Müller-Tidow C, Dreger P.   +9 more
europepmc   +1 more source

T-cell receptor gamma (TRG) diversity predicts peripheral blood involvement in primary cutaneous T-cell lymphoma. [PDF]

Blood Neoplasia
Ramesh R, Colbourn R, Van Deerlin VM, Halper-Stromberg E.   +3 more
europepmc   +1 more source

Assessment of Treatment Response in Patients With Scleromyxedema by the Double Modified Rodnan Skin Score

JEADV Clinical Practice, Volume 5, Issue 3, Page 917-921, September 2026.
ABSTRACT Background Scleromyxedema (SMX) is a cutaneous mucinosis characterised by an abnormal accumulation of mucin in the skin and limited treatment options. Assessment of therapy response during treatment is challenging. Objectives Patients with SMX receiving high‐dose intravenous IVIg therapy were included to assess validity of the double modified ...
Julia K. Winkler, Alexander H. Enk
wiley   +1 more source

Juvenile Mycosis Fungoides: A Multicenter Retrospective Italian Study

JEADV Clinical Practice, Volume 5, Issue 3, Page 839-845, September 2026.
This multicenter retrospective study included 29 juvenile mycosis fungoides (JMF) patients from five Italian centres with confirmed histopathological diagnosis. most often presents with hypopigmented/classic variants and CD8+ phenotype. Early‐onset cases ( < 14 years) show better long‐term outcomes.
Andrea Michelerio, Gabriele Roccuzzo, Iria Neri, Alessandro Pileri, Alessandro Svizzero, Maria Beatrice De Felici Del Giudice, Vieri Grandi, Pietro Quaglino, Valeria Brazzelli   +8 more
wiley   +1 more source

LAIR1 prevents excess inflammatory tissue damage in Staphylococcus aureus skin infection and Cutaneous T-cell Lymphoma. [PDF]

JCI Insight
Dorando HK, Mutic EC, Tomaszewski KL, Korshunova Y, Tian L, Stefanov MK, Quinn CC, Veis DJ, Bubeck Wardenburg J, Musiek AC, Mehta-Shah N, Payton JE.   +11 more
europepmc   +1 more source

Co-expression of CD30 and SLFN11 serves as a dual biomarker for the treatment of cutaneous T-cell lymphoma. [PDF]

NAR Cancer
Shimauchi T, Murai J, Iwasaki M, Phadungsaksawasdi P, Ojima T, Fujii K, Honda T.   +6 more
europepmc   +1 more source